Literature DB >> 21173574

Non-clustered protocadherin.

Soo-Young Kim1, Shin Yasuda, Hidekazu Tanaka, Kanato Yamagata, Hyun Kim.   

Abstract

The cadherin family is classified into classical cadherins, desmosomal cadherins and protocadherins (PCDHs). Genomic structures distinguish between PCDHs and other cadherins, and between clustered and non-clustered PCDHs. The phylogenetic analysis with full sequences of non-clustered PCDHs enabled them to be further classified into three subgroups: δ1 (PCDH1, PCDH7, PCDH9, PCDH11 and PCDH20), δ2 (PCDH8, PCDH10, PCDH12, PCDH17, PCDH18 and PCDH19) and ε (PCDH15, PCDH16, PCDH21 and MUCDHL). ε-PCDH members except PCDH21 have either higher or lower numbers of cadherin repeats than those of other PCDHs. Non-clustered PCDHs are expressed predominantly in the nervous system and have spatiotemporally diverse expression patterns. Especially, the region-specific expressions of non-clustered PCDHs have been observed in cortical area of early postnatal stage and in caudate putaman and/or hippocampal formation of mature brains, suggesting that non-clustered PCDHs play roles in the circuit formation and maintenance. The non-clustered PCDHs appear to have homophilic/heterophilc cell-cell adhesion properties, and each member has diverse cell signaling partnership distinct from those of other members (PCDH7/TAF1; PCDH8/TAO2β; PCDH10/Nap1; PCDH11/β-catenin; PCDH18/mDab1). Furthermore, each PCDH has several isoforms with differential cytoplasmic sequences, suggesting that one PCDH isoform could activate intracellular signaling differential from other isoforms. These facts suggest that non-clustered PCDHs play roles as a mediator of a regulator of other molecules as well as cell-cell adhesion. Furthermore, some non-clustered PCDHs have been considered to be involved in neuronal diseases such as autism-spectrum disorders, schizophrenia, and female-limited epilepsy and cognitive impairment, suggesting that they play multiple, tightly regulated roles in normal brain function. In addition, some non-clustered PCDHs have been suggested as candidate tumor suppressor genes in several tissues. Although molecular adhesive and regulatory properties of some PCDHs began to be unveiled, the endeavor to understand the molecular mechanism of non-clustered PCDH is still in its infancy and requires future study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21173574      PMCID: PMC3084973          DOI: 10.4161/cam.5.2.14374

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  91 in total

Review 1.  The diversity of cadherins and implications for a synaptic adhesive code in the CNS.

Authors:  L Shapiro; D R Colman
Journal:  Neuron       Date:  1999-07       Impact factor: 17.173

2.  A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome.

Authors:  Tamar Ben-Yosef; Seth L Ness; Anne C Madeo; Adi Bar-Lev; Jessica H Wolfman; Zubair M Ahmed; Robert J Desnick; Judith P Willner; Karen B Avraham; Harry Ostrer; Carole Oddoux; Andrew J Griffith; Thomas B Friedman
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

3.  The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.

Authors:  Min-Wei Chen; Francis Vacherot; Alexandre De La Taille; Sixtina Gil-Diez-De-Medina; Ruoqian Shen; Richard A Friedman; Martin Burchardt; Dominique K Chopin; Ralph Buttyan
Journal:  Oncogene       Date:  2002-11-07       Impact factor: 9.867

Review 4.  Protocadherins.

Authors:  Marcus Frank; Rolf Kemler
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

5.  Protocadherin Celsr3 is crucial in axonal tract development.

Authors:  Fadel Tissir; Isabelle Bar; Yves Jossin; Olivier De Backer; Andre M Goffinet
Journal:  Nat Neurosci       Date:  2005-03-20       Impact factor: 24.884

6.  Identification of 20 genes aberrantly methylated in human breast cancers.

Authors:  Kazuaki Miyamoto; Takashi Fukutomi; Sadako Akashi-Tanaka; Tadashi Hasegawa; Toshimasa Asahara; Takashi Sugimura; Toshikazu Ushijima
Journal:  Int J Cancer       Date:  2005-09-01       Impact factor: 7.396

7.  Distribution of OL-protocadherin protein in correlation with specific neural compartments and local circuits in the postnatal mouse brain.

Authors:  E Aoki; R Kimura; S T Suzuki; S Hirano
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype.

Authors:  Lorenza Ciani; Anjla Patel; Nicholas D Allen; Charles ffrench-Constant
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

9.  The cytoplasmic domain of Xenopus NF-protocadherin interacts with TAF1/set.

Authors:  Mike A Heggem; Roger S Bradley
Journal:  Dev Cell       Date:  2003-03       Impact factor: 12.270

10.  Cadherin activity is required for activity-induced spine remodeling.

Authors:  Ko Okamura; Hidekazu Tanaka; Yoshiki Yagita; Yoshinaga Saeki; Akihiko Taguchi; Yasushi Hiraoka; Ling-Hui Zeng; David R Colman; Naomasa Miki
Journal:  J Cell Biol       Date:  2004-11-29       Impact factor: 10.539

View more
  93 in total

1.  Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation.

Authors:  Laurianne Van Landeghem; M Agostina Santoro; Adrienne E Krebs; Amanda T Mah; Jeffrey J Dehmer; Adam D Gracz; Brooks P Scull; Kirk McNaughton; Scott T Magness; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-23       Impact factor: 4.052

Review 2.  Clustered protocadherins.

Authors:  Weisheng V Chen; Tom Maniatis
Journal:  Development       Date:  2013-08       Impact factor: 6.868

Review 3.  Protocadherins branch out: Multiple roles in dendrite development.

Authors:  Austin B Keeler; Michael J Molumby; Joshua A Weiner
Journal:  Cell Adh Migr       Date:  2015-04-14       Impact factor: 3.405

4.  Multiple protocadherins are expressed in brain microvascular endothelial cells and might play a role in tight junction protein regulation.

Authors:  Christina Dilling; Norbert Roewer; Carola Y Förster; Malgorzata Burek
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-17       Impact factor: 6.200

5.  A commentary on a case of new PCDH12 gene variants presented as dyskinetic cerebral palsy with epilepsy.

Authors:  Eraldo Fonseca Dos Santos-Junior; João Ricardo Mendes de Oliveira
Journal:  J Hum Genet       Date:  2018-06-14       Impact factor: 3.172

Review 6.  Regulation of cadherin expression in nervous system development.

Authors:  Alicia F Paulson; Maneeshi S Prasad; Amanda Henke Thuringer; Pasquale Manzerra
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

Review 7.  Cadherins and catenins in dendrite and synapse morphogenesis.

Authors:  Eunju Seong; Li Yuan; Jyothi Arikkath
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

8.  A case of new PCDH12 gene variants presented as dyskinetic cerebral palsy with epilepsy.

Authors:  Sato Suzuki-Muromoto; Keisuke Wakusawa; Takuya Miyabayashi; Ryo Sato; Yukimune Okubo; Wakaba Endo; Takehiko Inui; Noriko Togashi; Atsuko Kato; Hiroshi Oba; Mitsuko Nakashima; Hirotomo Saitsu; Naomichi Matsumoto; Kazuhiro Haginoya
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

9.  Sociability Deficits and Altered Amygdala Circuits in Mice Lacking Pcdh10, an Autism Associated Gene.

Authors:  Hannah Schoch; Arati S Kreibich; Sarah L Ferri; Rachel S White; Dominique Bohorquez; Anamika Banerjee; Russell G Port; Holly C Dow; Lucero Cordero; Ashley A Pallathra; Hyong Kim; Hongzhe Li; Warren B Bilker; Shinji Hirano; Robert T Schultz; Karin Borgmann-Winter; Chang-Gyu Hahn; Dirk Feldmeyer; Gregory C Carlson; Ted Abel; Edward S Brodkin
Journal:  Biol Psychiatry       Date:  2016-06-16       Impact factor: 13.382

Review 10.  Aberrant expression and functions of protocadherins in human malignant tumors.

Authors:  Ming Shan; Yonghui Su; Wenli Kang; Ruixin Gao; Xiaobo Li; Guoqiang Zhang
Journal:  Tumour Biol       Date:  2016-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.